Catherine C. Turkel, President at Novus Therapeutics, Inc. (NVUS), bought 805 shares at $3.97 ($3K) on 2018-09-05, disclosed to the SEC on 2018-09-07.
Open-market purchase of $3k NVUS by President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| NVUS | SELL | 2019-05-22 | $19K | — | Filing → |
| NVUS | BUY | 2018-09-13 | $322K | — | Filing → |
| NVUS | BUY | 2017-05-11 | $222K | — | Filing → |